Immune Response Study of Influenza Vaccine
Humoral and Cellular Immune Response Study of Influenza Vaccine
Sponsor: Centers for Disease Control and Prevention, China
A observational or N/A phase clinical study on Cell Mediated Reaction and Influenza Vaccine Allergy, this trial is completed. The trial is conducted by Centers for Disease Control and Prevention, China and has accumulated 10 data snapshots since 2011. Infectious disease trials contribute critical data for public health response and treatment development.
Status Flow
Change History
10 versions recorded-
Sep 2024 — Present [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Dec 2021 — Jul 2024 [monthly]
Completed
-
Jan 2021 — Dec 2021 [monthly]
Completed
-
Nov 2020 — Jan 2021 [monthly]
Completed
▶ Show 5 earlier versions
-
Jun 2018 — Nov 2020 [monthly]
Completed
-
May 2018 — Jun 2018 [monthly]
Completed
-
Apr 2018 — May 2018 [monthly]
Completed
Phase: NA → None
-
Aug 2017 — Apr 2018 [monthly]
Completed NA
-
Jan 2017 — Aug 2017 [monthly]
Completed NA
First recorded
Mar 2011
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Centers for Disease Control and Prevention, China
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
No location information available.